Black Diamond Therapeutics, Inc. 10-K filing
Filed 2026-03-16 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001701541-26-000009
- Form type
- 10-K
- CIK
- 0001701541
- Primary document
- https://www.sec.gov/Archives/edgar/data/1701541/000170154126000009/bdtx-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Black Diamond Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $12.5M | - | - |
| Net Income | $22.4M | - | - |
| Eps Basic | 0.39 | - | - |
| Eps Diluted | 0.39 | - | - |
| Cash And Equivalents | $21.0M | - | - |
| Total Assets | $143.0M | - | - |
| Total Liabilities | $30.8M | - | - |
| Shareholders Equity | $112.2M | - | - |
| Operating Cash Flow | $29.6M | - | - |